- Home
- RCUS vs SPNT Comparison
RCUS vs SPNT Comparison
Compare RCUS & SPNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RCUS | SPNT |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | Bermuda |
| Employees | N/A | 1099 |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.7B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | RCUS | SPNT |
|---|---|---|
| Price | $28.85 | $23.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $31.90 | $27.50 |
| AVG Volume (30 Days) | ★ 1.3M | 759.8K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $247,000,000.00 | N/A |
| Revenue This Year | N/A | $0.85 |
| Revenue Next Year | $45.62 | $5.85 |
| P/E Ratio | ★ N/A | $5.65 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.92 | $17.17 |
| 52 Week High | $29.85 | $24.32 |
Technical Indicators
Market Signals| Indicator | RCUS | SPNT |
|---|---|---|
| Relative Strength Index (RSI) | 69.69 | 60.11 |
| Support Level | $19.78 | $19.56 |
| Resistance Level | N/A | $24.09 |
| Average True Range (ATR) | 1.52 | 0.63 |
| MACD | 0.57 | 0.15 |
| Stochastic Oscillator | 88.14 | 88.38 |
Price Performance
Historical ComparisonAbout RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
About SPNT SiriusPoint Ltd.
SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.